46
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Laparoendoscopic single-site surgery in gynecology: LESS is actually how much less?

      other

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Gynecological surgery is evolving continuously. Laparoendoscopic single-site surgery (LESS) is the recent addition in this field that stands to benefit almost 40% of women in midlife who will eventually undergo adnexal surgery or hysterectomy. Carried out through a single umbilical incision, the potential benefit of single site surgery is improvement in operative morbidity and cosmesis. The safety, feasibility and efficacy of laparoendoscopic single site procedures have been established in studies over the last few years. In this article, we will review the nomenclature, instruments, and the evidence around the commonly performed gynecologic surgeries using the LESS procedure.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Surgical approach to hysterectomy for benign gynaecological disease.

          The three approaches to hysterectomy for benign disease are abdominal hysterectomy (AH), vaginal hysterectomy (VH), and laparoscopic hysterectomy (LH). Laparoscopic hysterectomy has three further subdivisions depending on the part of the procedure performed laparoscopically. To assess the most beneficial and least harmful surgical approach to hysterectomy for women with benign gynaecological conditions. We searched the Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials (15 August 2008), CENTRAL (The Cochrane Library 2008, Issue 3), MEDLINE (1950 to August 2008), EMBASE (1980 to August 2008), Biological Abstracts (1969 to August 2008), the National Research Register, and relevant citation lists. Only randomised controlled trials comparing one surgical approach to hysterectomy with another were included. Independent selection of trials and data extraction were employed following Cochrane guidelines. There were 34 included studies with 4495 women. The benefits of VH versus AH were speedier return to normal activities (mean difference (MD) 9.5 days), fewer febrile episodes or unspecified infections (odds ratio (OR) 0.42), and shorter duration of hospital stay (MD 1.1 days). The benefits of LH versus AH were speedier return to normal activities (MD 13.6 days), lower intraoperative blood loss (MD 45 cc), a smaller drop in haemoglobin (MD 0.55 g/dl), shorter hospital stay (MD 2.0 days), and fewer wound or abdominal wall infections (OR 0.31) at the cost of more urinary tract (bladder or ureter) injuries (OR 2.41) and longer operation time (MD 20.3 minutes). The benefits of LAVH versus TLH were fewer febrile episodes or unspecified infection (OR 3.77) and shorter operation time (MD 25.3 minutes). There was no evidence of benefits of LH versus VH and the operation time (MD 39.3 minutes) as well as substantial bleeding (OR 2.76) were increased in LH. For some important outcomes, the analyses were underpowered to detect important differences or they were simply not reported in trials. Data were absent for many important long-term outcome measures. Because of equal or significantly better outcomes on all parameters, VH should be performed in preference to AH where possible. Where VH is not possible, LH may avoid the need for AH however the length of the surgery increases as the extent of the surgery performed laparoscopically increases. The surgical approach to hysterectomy should be decided by the woman in discussion with her surgeon in light of the relative benefits and hazards.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: technique and initial report.

            Recent reports suggest that laparoendoscopic single-site surgery (LESS), also known as single-port surgery, is technically feasible in treating a variety of disease processes. The purpose of this study was to assess the feasibility of LESS for the surgical treatment of various gynecologic cancers or precancerous conditions through both laparoscopic and robotic-assisted approaches. A single institution retrospective review of patients treated with LESS on the gynecologic oncology service in 2009 was performed. Patients underwent surgery through a single 2-3 cm umbilical incision with a multi-channel SILS port for laparoscopic cases or a single-channel Gelport for robotic cases on the daVinci Surgical System. Thirteen patients had LESS surgery performed, nine done laparoscopically and four robotically. Procedures included endometrial cancer staging (n=1), ovarian cancer staging (n=1), retroperitoneal pelvic lymph node dissection (n=1), risk-reducing extrafascial hysterectomy/bilateral salpingo-oophorectomy (BSO, n=2) and BSO alone (n=5), and an ovarian cystectomy (n=1) and BSO (n=2) for complex adnexal masses. Median patient age and BMI were 47 years and 28, respectively. Median operating time was 65 min. All procedures were successfully performed via a single incision and no post-operative complications occurred. The majority of patients required no narcotics post-operatively. We present the first series of laparoendoscopic single-site surgery for the treatment of various gynecologic oncology conditions. LESS is feasible in select patients by laparoscopic or robotic-assisted techniques. Further studies are needed to better define the ideal gynecologic procedures for single-site surgery and to assess the benefits of LESS compared with more conventional minimally invasive approaches.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Consensus statement of the consortium for laparoendoscopic single-site surgery.

                Bookmark

                Author and article information

                Journal
                J Midlife Health
                J Midlife Health
                JMH
                Journal of Mid-Life Health
                Medknow Publications & Media Pvt Ltd (India )
                0976-7800
                0976-7819
                Jan-Mar 2013
                : 4
                : 1
                : 46-51
                Affiliations
                [1]Department of Reproductive Medicine, Sri Aurobindo Institute of Medical Sciences, Indore, Madhya Pradesh, India
                [1 ]Department of Obstetrics and Gynaecology, Air Force Hospital, Kanpur, Uttar Pradesh, India
                Author notes
                Address for correspondence: Dr. Priya Bhave Chittawar, Department of Reproductive Medicine, Sri Aurobindo Institute of Medical Sciences, MR 10 Crossing, Indore Ujjain State Highway, Indore - 453 111, Madhya Pradesh, India. E-mail: priyabhave1@ 123456gmail.com
                Article
                JMH-4-46
                10.4103/0976-7800.109638
                3702066
                23833535
                f4dea083-2df0-4309-8368-d91ef7efce42
                Copyright: © Journal of Mid-life Health

                This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Categories
                Surgeon's Corner

                Medicine
                adnexal surgery,hysterectomy,laparoendoscopic single site procedure,single incision laparoscopic surgery,single port surgery

                Comments

                Comment on this article